x
Filter:
Filters applied
- Clinical Practice Guidelines and Recommendations
- Desai, Chintan SRemove Desai, Chintan S filter
- LDL-CRemove LDL-C filter
Keyword
- ACC/AHA1
- Adult Treatment Panel III1
- American College of Cardiology/American Heart Association1
- ASCVD1
- ATP III1
- CAC1
- CHD1
- CVD1
- DM1
- Framingham Risk Score1
- FRS1
- IMPROVE-IT1
- Improved Reduction of Outcomes: Vytorin Efficacy International Trial1
- MESA1
- Multi-Ethnic Study of Atherosclerosis1
- National Health and Nutrition Examination Survey1
- NHANES1
- PHS1
- Physicians' Health Study1
- Reasons for Geographic and Racial Differences in Stroke1
- REGARDS1
- WHI-OS1
- WHS1
- Women's Health Initiative Observational Study1
Clinical Practice Guidelines and Recommendations
1 Results
- Review
Pathways Forward in Cardiovascular Disease Prevention One and a Half Years After Publication of the 2013 ACC/AHA Cardiovascular Disease Prevention Guidelines
Mayo Clinic ProceedingsVol. 90Issue 9p1262–1271Published online: August 11, 2015- Miguel Cainzos-Achirica
- Chintan S. Desai
- Libin Wang
- Michael J. Blaha
- Francisco Lopez-Jimenez
- Stephen L. Kopecky
- and others
Cited in Scopus: 16The 2013 American College of Cardiology/American Heart Association cardiovascular disease prevention guidelines represent an important step forward in the risk assessment and management of atherosclerotic cardiovascular disease in clinical practice. Differentiated risk prediction equations for women and black individuals were developed, and convenient 10-year and lifetime risk assessment tools were provided, facilitating their implementation. Lifestyle modification was portrayed as the foundation of preventive therapy.
